By
Bio-Pharmaceutical Plus officially launched in March 2022 in Australia aiming to distribute high quality pharmaceutical products globally. Currently Bio-pharmaceutical Plus is working with World Capital Biotechnology group or WCBG. This Australian company conducts highly innovative biotechnology research specializing in marine biotechnology and biocatalyst’s technology. WCBG and its partners have conducted technical research for the purposes of R&D, extraction, production, filling, packaging and marketing in Australia and New Zealand. This high-quality research involves health service solutions, testing and evaluation products, and the establishment of enterprise-scientific research expert workstations. Chief Executive Officer, Rory Sinclair, states that WCBG has technology from leading Australian laboratories and that this partnership will be highly beneficial.
